The role of deferred cytoreductive nephrectomy in the era of immune checkpoint inhibitor

被引：0
|
作者：
Yaegashi, Hiroshi [1 ]
机构：
[1] Kanazawa Univ, Dept Integrat Canc Therapy & Urol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY13-3
引用
收藏
页码：S1362 / S1362
页数：1
相关论文
共 50 条
  • [31] Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry
    Meagher, M. F.
    Minervini, A.
    Mir, M.
    Rebez, G.
    Autorino, R.
    Campi, R.
    Kriegmair, M.
    Linares, E.
    Hevia, V.
    Musquera, M.
    D'Anna, M.
    Rousel, E.
    Albersen, M.
    Pavan, N.
    Claps, F.
    Antonelli, A.
    Marchioni, M.
    Erdem, S.
    Paksoy, N.
    Derweesh, I
    EUROPEAN UROLOGY, 2021, 79 : S890 - S891
  • [32] Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma
    Crispen, Paul L.
    Blute, Michael L.
    CURRENT UROLOGY REPORTS, 2012, 13 (01) : 38 - 46
  • [33] CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS
    Shapiro, Daniel
    Ghasemzadeh, Ali
    Karam, Jose
    Zemp, Logan
    Master, Viraj
    Sexton, Wade
    Davaro, Facundo
    Schmeusser, Benjamin
    Patil, Dattatraya
    Matin, Surena
    Spiess, Philippe
    Abel, E. Jason
    JOURNAL OF UROLOGY, 2023, 209 : E369 - E370
  • [34] Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy for Renal Cell Carcinoma
    Paul L. Crispen
    Michael L. Blute
    Current Urology Reports, 2012, 13 : 38 - 46
  • [35] The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy
    Chowdhury, Simon
    Harper, Peter G.
    Choueiri, Toni K.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 698 - 699
  • [36] The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy
    Simon Chowdhury
    Peter G Harper
    Toni K Choueiri
    Nature Clinical Practice Oncology, 2008, 5 : 698 - 699
  • [37] The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern era
    Fortuna, Gliceida M. Galarza
    Maughan, Benjamin L.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (05) : 915 - 919
  • [38] A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy
    Gross, Evan E.
    Li, Mingjia
    Yin, Ming
    Orcutt, Delaney
    Hussey, Duncan
    Trott, Elliot
    Holt, Sarah K.
    Dwyer, Erin R.
    Kramer, Joel
    Oliva, Kaylee
    Gore, John L.
    Schade, George R.
    Lin, Daniel W.
    Tykodi, Scott S.
    Hall, Evan T.
    Thompson, John A.
    Parikh, Anish
    Yang, Yuanquan
    Collier, Katharine A.
    Miah, Abdul
    Mori-Vogt, Sherry
    Hinkley, Megan
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven K.
    Psutka, Sarah P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (01) : 51.e25 - 51.e31
  • [39] Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
    Meagher, Margaret F.
    Minervini, Andrea
    Mir, Maria C.
    Cerrato, Clara
    Rebez, Giacomo
    Autorino, Riccardo
    Hampton, Lance
    Campi, Riccardo
    Kriegmair, Maximilian
    Linares, Estefania
    Hevia, Vital
    Musquera, Maria
    D'Anna, Mauricio
    Roussel, Eduard
    Albersen, Maarten
    Pavan, Nicola
    Claps, Francesco
    Antonelli, Alessandro
    Marchioni, Michele
    Paksoy, Nail
    Erdem, Selcuk
    Derweesh, Ithaar H.
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 63 : 71 - 80
  • [40] The evolving role of cytoreductive nephrectomy
    Singla, Nirmish
    Hakimi, A. Ari
    Margulis, Vitaly
    CURRENT OPINION IN UROLOGY, 2019, 29 (05) : 505 - 506
12345